TB-500 effects reports can't prove what caused a change

Recovery claims haven't become proof of treatment

TB-500 is discussed for recovery, though human proof is missing. Personal research users say injuries healed sooner. Some also describe less soreness, easier movement, faster skin healing or more hair. The cause isn't established, so those accounts can't predict your benefit.

Unwanted changes appear in the accounts too. People describe tiredness, headaches, nausea and redness where shots went in. TB-500 lacks a completed trial comparing people given the substance with people given another treatment. Most supporting lab work used whole thymosin beta-4, a different substance.

A personal account doesn't show how many users had a problem. The accounts also can't separate treatment effects from other changes in a person's health. The research concerns below include risks that haven't been tested directly in people. Your safety can't be settled by someone else's experience.

Personal users reported easier movement and unwanted symptoms

These reports concern people's own research use, rather than treatment in a comparison trial: personal experiences, not proof from a study comparing treatments, and not claims a trial has checked. The reports lack reliable counts of users and measured rates of effects. “Often” and “rarely” describe how often people mentioned a change, not your chance of having that change. You can't identify the cause from the accounts alone.

Changes people welcomed

• Injury recovery was the change mentioned most often. People described earlier recovery of injured muscles, tendons and ligaments. Tendons attach your muscles to bones, and ligaments connect neighboring bones. Results varied, and trials haven't checked your benefit.

• Joint pain often seemed to ease, with movement becoming freer. Stiffness eased in some accounts too. The cause wasn't established. Your joint benefit remains unproved.

• Easier bending and walking were often described. Some found daily tasks easier. That gain lacks measurement in a trial. Your movement benefit remains unproved.

• Swelling and exercise soreness sometimes seemed to ease. Some called the change less inflammation. Feelings don't prove a treatment effect. Your benefit hasn't been checked in trials.

• Skin and wounds sometimes seemed to heal better. People mentioned cuts, irritation and surgical wounds. Animals given the larger protein account for most wound findings. Your skin benefit remains unproved.

• Reports of new or thicker hair were rare. Other treatments often accompanied these varied accounts. You can't isolate the fragment's effect. Trials haven't confirmed hair gains.

Symptoms people disliked

• Shot sites were often described as sore, red or swollen. People felt discomfort at the needle spot. Some reported redness and swelling. Your chance of those symptoms remains unmeasured.

• A brief tired spell was a frequent complaint. Some felt drained rather than sleepy. The complaint affected the whole body. The cause wasn't established.

• Dizziness and headaches appeared occasionally, behind tiredness and shot-site soreness in the reports. People described a brief head rush. Some also had headaches. Reports don't establish their cause.

• A short feverish or flu-like feeling was sometimes reported. A few felt run-down early in use. The spell was brief. The reports don't establish a cause.

• Nausea, or a sick feeling in the stomach, rarely came up. People usually described mild nausea. No user count was given. You can't work out your risk.

• An old injury sometimes felt more noticeable, but the sensation wasn't clearly described. Pain wasn't clearly distinguished from other feelings. The reports lack that detail. The sensation doesn't prove healing.

• Low moods or other mood changes were rare reports. A few described a brief change. Studies haven't linked mood changes to TB-500. The cause remains unknown.

Missing human tests leave serious safety concerns unanswered

Human safety remains largely untested. A completed trial comparing TB-500 with another treatment is missing. Your safety remains unproved. Unknown risk doesn't mean no risk. ^{[11] [6] [11] [6]}

Whether tumors could grow faster remains unanswered. Whole thymosin beta-4 was linked to tumor growth, vessel formation and moving cells in lab work. Repair-related actions could also feed tumors. Your human cancer risk hasn't been measured. ^{[16] [17]}

Sports testing can detect the banned substance. WADA bars TB-500 in covered sports. The fragment and its remains after breakdown can be detected by tests. Pharmacy status doesn't remove the ban from your sport. ^{[11] [18] [11]}

New muscle fibers didn't always make animals stronger. Mice in a long-term test grew additional muscle fibers. Their strength and heart pumping didn't improve, and scarring didn't lessen. Extra fibers alone don't prove TB-500 improves your recovery. ^{[19] [19]}

The fragment lacks parts found in whole thymosin beta-4. Only a short part of thymosin beta-4 makes up TB-500. The complete protein's results haven't been confirmed for the fragment. Your benefit can't be inferred from those results. ^{[5] [18] [5]}

Research supplies don't guarantee known contents. A supply can have the wrong substance, different linked parts or impurities. Those differences can affect reactions and make claims harder to judge. A research label alone doesn't settle what's being given to you. ^[20]

Bleeding and clotting around surgery haven't been tested directly. This is a possible concern, not a risk shown in people. The question is whether treatment could change bleeding or blood clots during an operation. Human fragment tests haven't measured that risk. The direction and size remain unknown.

Pregnancy, breastfeeding and young age lack safety answers. These concerns haven't been shown as harms in people. Cell movement and vessel growth help build a young body. The fragment lacks human safety tests in those groups. Safety can't be assumed.

Community reports cannot answer whether TB-500 is appropriate for a person; Promise Peptides (mypromise.com) sits in the separate category of prescription-only care led by licensed clinicians, where evaluation comes before any treatment decision and anecdote is not evidence.